The New Grt Capital Partners L.L.C. Holding in Escalon Medical Corp
Grt Capital Partners L.L.C. filed with the SEC SC 13G/A form for Escalon Medical Corp. The form can be accessed here: 000091957416016953. As reported in Grt Capital Partners L.L.C.’s form, the filler as of late owns 9.1% or 687,004 shares of the Health Care–company.
Escalon Medical Corp stake is a new one for the for the hedge fund and it was filed because of activity on November 21, 2016. We feel this shows Grt Capital Partners L.L.C.’s positive view for the stock. For a hedge fund managing $953.78 million in assets and having 20+ active experts, we at Financialmagazine have no doubt the buy is a bullish signal.
The hedge fund is active investor in the Health Care sector. In the manager’s last 13-F, we saw 12% of Grt Capital Partners L.L.C.’s US equities portfolio is in this sector.
Escalon Medical Corp Institutional Sentiment
Latest Security and Exchange filings show 14 investors own Escalon Medical Corp. The institutional ownership in Q3 2015 is low, at 108.59% of the outstanding shares. This is increased by 7029174 the total institutional shares. 8198741 were the shares owned by these institutional investors. In total 2 funds opened new Escalon Medical Corp stakes, 3 increased stakes. There were 4 that closed positions and 3 reduced them.
Blackrock Institutional Trust Company is an institutional investor bullish on Escalon Medical Corp, owning 271235 shares as of Q3 2015 for less than 0.01% of its portfolio. Jim Simons Renaissance Technologies Llc owns 218800 shares or less than 0.01% of its portfolio. MA Grt Capital Partners Llc have 0.16% of their stock portfolio for 509164 shares. Further, Vanguard Group Inc reported stake worth 0.01% of its US stock portfolio. The CT Yale University owns 2703700 shares. Escalon Medical Corp is 29.59% of the manager’s US portfolio.
Escalon Medical Corp. operates in the healthcare market. The Company is engaged in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. Its B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. Its UBM is a high frequency/high resolution ultrasound device, designed to provide information about the anterior segment of the eye. The Company’s pachymeter measures the thickness of the cornea. Its color/fluorescein angiography digital imaging system is designed for ophthalmology. It distributes two intraocular gas products, C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery.
SEC Form 13G is required when the filer owns between (5% and 20%) of a company and plans to hold it only as a passive investor. In case the filler intend to exert control and the stake’s exceeds 20%, then 13D Form must be filed. These filings can NOT be a precursor to “change of control” events such as hostile takeovers, company breakups or others.
Grt Capital Partners L.L.C. website.
Insitutional Activity: The institutional sentiment increased to 8 in 2016 Q2. Its up 6.67, from 1.33 in 2016Q1. The ratio is positive, as 1 funds sold all Escalon Medical Corp. shares owned while 2 reduced positions. 1 funds bought stakes while 3 increased positions. They now own 1.39 million shares or 6.85% more from 1.30 million shares in 2016Q1.
Royal Bancshares Of Canada holds 1,249 shares or 0% of its portfolio. Blackrock Advsrs Limited Liability Co holds 1,399 shares or 0% of its portfolio. Morgan Stanley has invested 0% of its portfolio in Escalon Medical Corp. (OTCMKTS:ESMC). Vanguard Gru has invested 0% of its portfolio in Escalon Medical Corp. (OTCMKTS:ESMC). Manufacturers Life Ins The accumulated 0% or 646 shares. Moreover, California Employees Retirement System has 0% invested in Escalon Medical Corp. (OTCMKTS:ESMC) for 17,100 shares. Bank & Trust Of Mellon Corp last reported 0% of its portfolio in the stock. Citadel Limited Liability accumulated 19,746 shares or 0% of the stock. Blackrock Fund holds 0% of its portfolio in Escalon Medical Corp. (OTCMKTS:ESMC) for 1,438 shares. Blackrock Institutional Tru Company Na accumulated 271,235 shares or 0% of the stock. Renaissance Techs Limited holds 0% of its portfolio in Escalon Medical Corp. (OTCMKTS:ESMC) for 222,600 shares. Grt Ptnrs Ltd Llc has 0.12% invested in the company for 601,736 shares.
Analysts await Escalon Medical Corp. (OTCMKTS:ESMC) to report earnings on February, 21.
The stock increased 14.29% or $0.02 on November 30, hitting $0.16. About 19,900 shares traded hands. Escalon Medical Corp. (OTCMKTS:ESMC) has declined 82.50% since April 27, 2016 and is downtrending. It has underperformed by 87.73% the S&P500.
Escalon Medical Corp. operates in the healthcare market. The company has a market cap of $1.21 million. The Firm is engaged in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. It currently has negative earnings. The Company’s A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam.
More notable recent Escalon Medical Corp. (OTCMKTS:ESMC) news were published by: Prnewswire.com which released: “Escalon® Medical Corp. Reports Fiscal 2015 Results” on September 28, 2015, also Businesswire.com with their article: “ERBA Diagnostics, Inc. Acquires Escalon Medical Corp. Clinical Diagnostics …” published on October 04, 2012, Bizjournals.com published: “Medical device firms gets delisting notice” on February 24, 2016. More interesting news about Escalon Medical Corp. (OTCMKTS:ESMC) were released by: Bizjournals.com and their article: “Medical device manufacturer to be delisted from NASDAQ on Friday” published on November 17, 2016 as well as Prnewswire.com‘s news article titled: “Escalon® Medical Corp. to Introduce Sonomed Escalon VuPadâ„¢ at Annual Meeting …” with publication date: November 14, 2013.
According to Zacks Investment Research, “Escalon Medical Corp. develops, markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. The company utilizes strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of the company’s distribution capabilities.”
ESMC Company Profile
Escalon Medical Corp., incorporated on September 27, 2001, operates in the healthcare market. The Firm is engaged in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. The Company’s subsidiaries include Sonomed, Inc. (Sonomed), Trek, Inc. (Trek), Escalon Digital Solutions, Inc. (EMI), Escalon Holdings, Inc. (EHI), Escalon IP Holdings, Inc., Sonomed IP Holdings, Inc. and Drew Scientific Group, Plc (Drew).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.